Skip to content
ApprovedFDA approvedStrong evidence

Agomelatine

Prescription antidepressant that also restores the sleep-wake rhythm; liver function must be checked regularly.

AntidepressantSleep SupportAntidepressantMoodSerotoninDopaminenoo.affects.sleep
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassAntidepressant · Mood
Primary targetMelatonin MT1/MT2 agonism and 5-HT2C antagonism
Targets3 receptor targets
Half-life~1-2 hours (short; metabolized by hepatic CYP1A2)
OnsetAntidepressant effect usually appears after 1-2 weeks; sleep improvement often sooner
EvidenceStrong evidence
Affected systemsSerotoninDopaminenoo.affects.sleep

Contents

DETAILED OVERVIEW

What is Agomelatine?

Agomelatine is a prescription antidepressant, a medicine for depression, approved for major depression in adults. Sold as Valdoxan and Thymanax, it has been available in the European Union since 2009 but was never approved in the United States.

It works in two ways. By acting on melatonin receptors (melatonin is the hormone that sets the sleep-wake rhythm), it restores the sleep rhythm that depression throws off. By blocking one serotonin receptor, it also raises dopamine and noradrenaline in the front of the brain, which lifts mood. In studies it worked about as well as standard antidepressants, with less sexual trouble and weight gain. Its main risk is a rise in liver enzymes, and rarely serious liver damage, so regular liver tests are mandatory; it cannot be taken with active liver disease. It must not be combined with certain drugs (for example fluvoxamine), and there is too little data on its safety in pregnancy and breastfeeding.

Mechanism

MT1/MT2 agonist + 5-HT2C antagonist

Half-life

~1-2 hours (dosed at bedtime)

Legal status

Prescription antidepressant (EMA 2009)

Receptor profile

  • Melatonin MT1/MT2 receptors (agonist)Strong
  • Serotonin 5-HT2C receptors (antagonist)Moderate
  • Frontal cortex dopamine and noradrenaline (indirect increase)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Nausea, dizziness and headache, typically in the first weeks of treatment
  • Elevated liver enzymes (transaminases): periodic liver function monitoring is mandatory
  • Rare but serious liver injury (hepatitis, hepatic failure) warranting discontinuation
  • Somnolence or fatigue, or in some people disturbed sleep and vivid dreams
  • Anxiety, restlessness, digestive complaints (diarrhea, abdominal pain)

Contraindications · 4

  • Active liver disease or transaminases above three times the upper normal limit: contraindicated
  • Concomitant strong CYP1A2 inhibitors (fluvoxamine, ciprofloxacin): contraindicated due to greatly increased exposure
  • Elderly patients with dementia: efficacy and safety not established
  • Pregnancy and breastfeeding: insufficient human data, medical judgment required

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Agomelatine is a prescription-only medication used mainly to treat depression in adults. It works through a dual mechanism: it helps reset the sleep-wake rhythm via the melatonin system, improving sleep quality and continuity, while also lifting mood in a way comparable to standard antidepressants. Compared to typical SSRIs, it tends to cause fewer sexual side effects and less weight gain.

Telegram

Have a question about Agomelatine?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAntidepressant
FormulaC15H17NO2
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.